United States Biotechnology & Medical Research

Dermata Therapeutics Inc (DRMA)

Track

Dermata Therapeutics Inc. recorded one insider transaction over the past 90 days, consisting of a sale of 11 shares valued at approximately $13.09 by Kathleen D. Scott on June 16, 2026. This follows a period where the stock price declined by 10% over the last quarter, despite a positive earnings report in May 2026.
Ticker: DRMA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 16 Jun 2026
Value US$2,883,722.08 | Price 413.73 | Shares 38,783 (+4.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-16 2026-06-16 S Sale
2.9
Scott Kathleen D.
Non-Executive Director
38,783 +4.5%
413.73
US$2,883,722 		38,783 +4.5% 413.73 US$2,883,722
2026-03-17 2026-02-17 B Purchase
1.5
Bedoya-Toro Munera Maria E

SVP, Regulatory Affairs

Officer
44,325 -40.1%
454.64
US$2,074,107 		44,325 -40.1% 454.64 US$2,074,107
2021-11-26 2021-11-23 B Purchase
0.5
PROEHL GERALD T

President, CEO and Chairman

Executive Director Large shareholder
62,440 -20.6%
241.80
US$2,337,879 		62,440 -20.6% 241.80 US$2,337,879
Explore more

More insider trading research around Dermata Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America